SPB Earnings

SPB reported its FY2026Q1 earnings on 2026-02-05, showcasing a revenue of 0.00 against an estimate of 666.00M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.77 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following SPB's FY2026Q1 earnings announcement on 2026-02-05, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, SPB's stock price tends to shift by an average of -0.97% in the 10 days leading up to earnings and -0.93% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate SPB’s annual revenue to reach 668.00M, while the EPS is projected at 1.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 0.35% and EPS estimates Revise Downward by -0.92% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between SPB's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2026 were Revise Upward by 0.35%, while EPS estimates moved Revise Downward by -0.92% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, SPB's stock price typically moves by -0.97% in the 10 days before its earnings and -0.93% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 1.00 and revenue of 668.00M.

The earnings call revealed mixed performance: Global Pet Care and Home & Garden showed positive trends, while Home & Personal Care struggled. The Q&A highlighted management's strategic focus and optimism but lacked clarity on tariffs and M&A. Positive factors include a strong shareholder return plan, cost reductions, and diversification efforts. However, the decline in Home & Personal Care sales and cautious consumer behavior are concerns. Given the market cap and mixed signals, the stock is likely to remain stable, resulting in a neutral outlook.